European Biopharmaceutical Review (EBR)

European Biopharmaceutical Review (EBR)

Biotechnology Research

European Biopharmaceutical Review (EBR) provides a dedicated platform for the European biopharmaceutical market.

About us

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America, and the rest of the world. With editorial consisting of in-depth articles, case studies, meetings, and report reviews written by specialists with hands-on experience in the biopharma industry; traditional multi-national pharma companies; investment houses; and industry-associated governmental, economic, and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories. Connect with us on Twitter: follow @EBRmagazine

Industry
Biotechnology Research
Company size
2-10 employees
Specialties
biopharmaceuticals and biotech

Updates

Affiliated pages

Similar pages